Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent Advances in Cancer Immunotherapy.

Literature DB >> 33672298

Recent Advances in Cancer Immunotherapy.

Abstract

The strategy to use the immune system to fight cancer is not a novel concept; in 1891, Coley reported the treatment of three cases of sarcoma by inoculation with erysipelas [...].

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2021 PMID： 33672298 PMCID： PMC7927083 DOI： 10.3390/biom11020335

Source DB: PubMed Journal: Biomolecules ISSN： 2218-273X

9 in total

1. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).

Authors: Masaki Shimoji; Shigeki Shimizu; Katsuaki Sato; Kenichi Suda; Yoshihisa Kobayashi; Kenji Tomizawa; Toshiki Takemoto; Tetsuya Mitsudomi
Journal: Lung Cancer Date: 2016-05-25 Impact factor: 5.705

2. II. Contribution to the Knowledge of Sarcoma.

Authors: W B Coley
Journal: Ann Surg Date: 1891-09 Impact factor: 12.969

Review 3. The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors.

Authors: Evangelos Koustas; Panagiotis Sarantis; Athanasios G Papavassiliou; Michalis V Karamouzis
Journal: Biomolecules Date: 2020-04-25

Review 4. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.

Authors: Alexandre Perrier; Audrey Didelot; Pierre Laurent-Puig; Hélène Blons; Simon Garinet
Journal: Biomolecules Date: 2020-07-16

Review 5. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.

Authors: Taku Fujimura; Setsuya Aiba
Journal: Biomolecules Date: 2020-07-22

Recent Advances in Cancer Immunotherapy.

1. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).

2. II. Contribution to the Knowledge of Sarcoma.

Review 3. The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors.

Review 4. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.

Review 5. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.

6. A decade of immune-checkpoint inhibitors in cancer therapy.

7. Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cells.

8. Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas.

Review 9. The Possibilities of Immunotherapy for Children with Primary Immunodeficiencies Associated with Cancers.